Related Articles
Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma
RRM2‑mediated Wnt/β‑catenin signaling pathway activation in lung adenocarcinoma: A potential prognostic biomarker
miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo Retraction in /10.3892/or.2023.8558
Ribonucleotide reductase M2 is a promising molecular target for the treatment of oral squamous cell carcinoma
HSP47 is associated with the prognosis of laryngeal squamous cell carcinoma by inhibiting cell viability and invasion and promoting apoptosis